SILVER SPRING, Md. — A U.S. Food and Drug Administration panel Friday unanimously recommended expanding the approved uses of leading cancer drug Taxol for patients with early-stage breast cancer.
Taxol, sold by Bristol-Myers Squibb Co., is the world's most widely used cancer drug. It already has the government's approval for fighting metastatic breast cancer and some lung cancers. It also is the leading drug for ovarian cancer and had 1998 sales of $1.2 billion.